Guoming Wu

1.0k total citations
22 papers, 728 citations indexed

About

Guoming Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Guoming Wu has authored 22 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Guoming Wu's work include Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Guoming Wu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Guoming Wu collaborates with scholars based in China and United States. Guoming Wu's co-authors include Guisheng Qian, Chunxue Bai, Xiaoju Zhang, Qunying Hong, Qi Wang, Xin Gong, Fuyun Ji, Weimin Li, Chengping Hu and Jing Li and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Guoming Wu

22 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoming Wu China 12 317 288 271 163 63 22 728
Koichi Saruwatari Japan 12 333 1.1× 212 0.7× 342 1.3× 110 0.7× 69 1.1× 38 694
Sebahat Ocak Belgium 17 244 0.8× 289 1.0× 175 0.6× 92 0.6× 79 1.3× 36 694
Ettore D’Argento Italy 18 218 0.7× 382 1.3× 538 2.0× 160 1.0× 90 1.4× 52 890
Frédéric Vallot Belgium 7 251 0.8× 268 0.9× 359 1.3× 109 0.7× 62 1.0× 18 613
Marko Jakopović Croatia 16 234 0.7× 402 1.4× 262 1.0× 133 0.8× 183 2.9× 93 937
Olga Nigro Italy 11 173 0.5× 168 0.6× 340 1.3× 99 0.6× 69 1.1× 41 643
Yunan Han United States 16 152 0.5× 216 0.8× 337 1.2× 137 0.8× 35 0.6× 39 705
Zoltán Lohinai Hungary 16 353 1.1× 273 0.9× 416 1.5× 93 0.6× 103 1.6× 40 760
Ying Tian China 16 347 1.1× 112 0.4× 236 0.9× 177 1.1× 47 0.7× 40 686
Eun Ji Jung South Korea 14 378 1.2× 159 0.6× 312 1.2× 141 0.9× 88 1.4× 24 781

Countries citing papers authored by Guoming Wu

Since Specialization
Citations

This map shows the geographic impact of Guoming Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoming Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoming Wu more than expected).

Fields of papers citing papers by Guoming Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoming Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoming Wu. The network helps show where Guoming Wu may publish in the future.

Co-authorship network of co-authors of Guoming Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Guoming Wu. A scholar is included among the top collaborators of Guoming Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoming Wu. Guoming Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qiongyue, Yonghao Feng, Dou Wu, et al.. (2024). Serum Metabolomic and Lipidomic Profiling Reveals the Signature for Postoperative Obesity among Adult-Onset Craniopharyngioma. Metabolites. 14(6). 338–338. 2 indexed citations
2.
He, Chunyan, Chuan Liu, Shiyong Yu, et al.. (2021). Atrial performance in healthy subjects following high altitude exposure at 4100 m: 2D speckle-tracking strain analysis. International journal of cardiac imaging. 37(6). 1891–1902. 7 indexed citations
3.
Yang, Yuanqi, Chuan Liu, Shiyong Yu, et al.. (2020). Pulmonary function tests at low altitude predict pulmonary pressure response to short-term high altitude exposure. Respiratory Physiology & Neurobiology. 282. 103534–103534. 4 indexed citations
4.
Lu, Shaohua, Hui Kong, Yingyong Hou, et al.. (2018). Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer. Lung Cancer. 123. 44–51. 80 indexed citations
5.
Han, Baohui, Kai Li, Yizhuo Zhao, et al.. (2018). Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302). British Journal of Cancer. 118(5). 654–661. 195 indexed citations
6.
Xu, Zhi, Guoming Wu, Qi Li, et al.. (2018). Predictive Value of Combined LIPS and ANG-2 Level in Critically Ill Patients with ARDS Risk Factors. Mediators of Inflammation. 2018. 1–10. 19 indexed citations
7.
Yang, Dawei, Xiaoju Zhang, Charles A. Powell, et al.. (2017). Probability of cancer in high‐risk patients predicted by the protein‐based lung cancer biomarker panel in China: LCBP study. Cancer. 124(2). 262–270. 34 indexed citations
8.
Qian, Pin, Ruijie Zhang, Qi Li, et al.. (2016). The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population. Oncotarget. 7(37). 59742–59753. 11 indexed citations
9.
Zhang, Ruijie, Wei Yao, Pin Qian, et al.. (2015). Increased sensitivity of human lung adenocarcinoma cells to cisplatin associated with downregulated contactin-1. Biomedicine & Pharmacotherapy. 71. 172–184. 17 indexed citations
10.
Li, Fang, Zhi Xu, Guansong Wang, et al.. (2014). Directed Evolution of an LBP/CD14 Inhibitory Peptide and Its Anti-Endotoxin Activity. PLoS ONE. 9(7). e101406–e101406. 18 indexed citations
11.
Wu, Guoming, Caicun Zhou, Chunxue Bai, & Guisheng Qian. (2014). Chinese expert consensus on molecularly targeted therapy for advanced non-small cell lung cancer (2013 edition).. PubMed. 6(10). 1489–98. 4 indexed citations
12.
Wu, Guoming, Haidong Li, Pin Qian, et al.. (2013). Promoter Methylation Profiles between Human Lung Adenocarcinoma Multidrug Resistant A549/Cisplatin (A549/DDP) Cells and Its Progenitor A549 Cells. Biological and Pharmaceutical Bulletin. 36(8). 1310–1316. 24 indexed citations
13.
Wang, Bin, et al.. (2013). [Diagnostic value of computed tomography-guided percutaneous lung biopsy for malignant lung tumors].. PubMed. 93(38). 3023–6. 3 indexed citations
14.
Wang, Changzheng, Guisheng Qian, Guoming Wu, et al.. (2012). Role of mtDNA haplogroups in COPD susceptibility in a southwestern Han Chinese population. Free Radical Biology and Medicine. 53(3). 473–481. 20 indexed citations
15.
Qian, Pin, Guisheng Qian, Changzheng Wang, et al.. (2012). Association of Mitochondrial DNA Variations with Lung Cancer Risk in a Han Chinese Population from Southwestern China. PLoS ONE. 7(2). e31322–e31322. 37 indexed citations
16.
Yang, Heping, Gensheng Lu, Xiongfei Wu, et al.. (2012). Prulifloxacin versus Levofloxacin in the Treatment of Respiratory and Urinary Tract Infections: A Multicentre, Double-Blind, Randomized Controlled Clinical Trial. Chemotherapy. 58(3). 249–256. 3 indexed citations
17.
Jia, Bei, Ping Lu, Wenxiang Huang, et al.. (2010). A Multicenter, Randomized Controlled Clinical Study on Biapenem and Imipenem/Cilastatin Injection in the Treatment of Respiratory and Urinary Tract Infections. Chemotherapy. 56(4). 285–290. 18 indexed citations
18.
Han, Lei, et al.. (2008). [Transfection of human beta defensin 2 gene into the lung by aerosol inhalation: experiment with rats].. PubMed. 88(20). 1425–8. 2 indexed citations
19.
Yu, Shi‐Cang, et al.. (2007). Efficacy of Chemotherapeutic Agents Under Hypoxic Conditions in Pulmonary Adenocarcinoma Multidrug Resistant Cell Line. Journal of Chemotherapy. 19(2). 203–211. 7 indexed citations
20.
Wu, Guoming, et al.. (2004). [The effect of Na(+)/H(+) exchanger-1 (NHE-1) antisense expression vector on NHE-1 gene expression in human lung adenocarcinoma cells and its biological significance].. PubMed. 27(3). 191–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koichi Saruwatari Breakdown of academic impact, for papers by Sebahat Ocak Breakdown of academic impact, for papers by Ettore D’Argento Breakdown of academic impact, for papers by Frédéric Vallot Breakdown of academic impact, for papers by Marko Jakopović Breakdown of academic impact, for papers by Olga Nigro Breakdown of academic impact, for papers by Yunan Han Breakdown of academic impact, for papers by Zoltán Lohinai Breakdown of academic impact, for papers by Ying Tian Breakdown of academic impact, for papers by Eun Ji Jung
Rankless by CCL
2026